Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

124 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07259317

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations: Site 02 Scottsdale, Arizona, United States

Site 04 Los Angeles, California, United States

Site 12 Orange, California, United States

Site 06 Atlanta, Georgia, United States

View all 15 locations

View Trial Details

Recruiting

Prospective Data Collection Initiative on Thoracic Malignancies

NCT06996249

Conditions: Adenocarcinoma, Adenoma, Bronchial Neoplasms, +25 more
Locations: Ziekenhuis Gelderse Vallei Ede, Gelderland, Netherlands

Máxima MC Eindhoven, North Brabant, Netherlands

Tergooi MC Hilversum, Utrecht, Netherlands

Diakonessenhuis Utrecht, Netherlands

View all 23 locations

View Trial Details

Recruiting

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

NCT05581121

Conditions: Adenocarcinoma, Adenosquamous Carcinoma, Carcinoma, +18 more
Locations: UH Ostrava - FNO Ostrava, Czechia

UH Plzeň Pilsen, Czechia

General UH in Prague - VFN Prague, Czechia

Institut de Cancérologie de l'Ouest Angers, France

View all 37 locations

View Trial Details

Recruiting

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

NCT02133196

Conditions: Adenocarcinoma, Adenosquamous Carcinoma, Advanced NSCLC, +23 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

NCT07628634

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +47 more
Locations: Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States

View Trial Details

Recruiting

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT06794073

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

NCT05065736

Conditions: Adenocarcinoma, Carcinoma, Metastatic Cancer, +7 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

NCT06128343

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations: Béthune hospital center Béthune, France

Haut-Lévêque Hospital Bordeaux, France

Huriez Hospital Lille, France

Jean Mermoz private hosptila Lyon, France

View Trial Details

Recruiting

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

NCT06046131

Conditions: Adenocarcinoma, Carcinoma, Disease Attributes, +19 more
Locations: CHU of Rennes Rennes, Ille-et-Vilaine, France

CHU of Guadeloupe Pointe-à-Pitre, Guadeloupe

View Trial Details

Recruiting

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

NCT04361708

Conditions: Adenocarcinoma, Carcinoma, Gastroesophageal Junction Adenocarcinoma, +4 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions